EcoDrugPlus

Tyrosinase

Ensembl ID : ENSUAMG00000012939
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSUAMG00000020830
Gene Symbol: TH
1 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSUAMG00000018663
Gene Symbol: TYK2
2 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSUAMG00000000981
Gene Symbol: TIE1
2 Cross references
203 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSUAMG00000015898
Gene Symbol: VEGFA
2 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSUAMG00000026772
Gene Symbol: VDR
2 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSUAMG00000008727
Gene Symbol: VKORC1
2 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSUAMG00000011743
Gene Symbol: XDH
2 Cross references
211 Possible Orthologues:

Ensembl ID : ENSUAMG00000017646
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSUAMG00000013811
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSUAMG00000013752
Gene Symbol: -
Cross references: -
660 Possible Orthologues:

Ensembl ID : ENSUAMG00000013634
Gene Symbol: -
Cross references: -
287 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).